Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Next-generation cell therapies: the emerging role of CAR-NK cells
Rafet Başar, May Daher, Katayoun Rezvani
Blood Advances (2020) Vol. 4, Iss. 22, pp. 5868-5876
Open Access | Times Cited: 108

Showing 1-25 of 108 citing articles:

CAR-cell therapy in the era of solid tumor treatment: current challenges and emerging therapeutic advances
Karama Makni‐Maalej, Maysaloun Merhi, Varghese Inchakalody, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 277
CAR-NK Cells in the Treatment of Solid Tumors
Ewa Wrona, Maciej Borowiec, Piotr Potemski
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 11, pp. 5899-5899
Open Access | Times Cited: 105
Emerging Targeted Therapies for HER2-Positive Breast Cancer
María F. Mercogliano, Sofía Bruni, Florencia Mauro, et al.
Cancers (2023) Vol. 15, Iss. 7, pp. 1987-1987
Open Access | Times Cited: 76
Innate lymphoid cells and innate-like T cells in cancer — at the crossroads of innate and adaptive immunity
Benjamin Ruf, Tim F. Greten, Firouzeh Korangy
Nature reviews. Cancer (2023) Vol. 23, Iss. 6, pp. 351-371
Closed Access | Times Cited: 48
Advancing cell-based cancer immunotherapy through stem cell engineering
Yan-Ruide Li, Zachary Spencer Dunn, Yanqi Yu, et al.
Cell stem cell (2023) Vol. 30, Iss. 5, pp. 592-610
Open Access | Times Cited: 41
A new age of precision gene therapy
Axel Schambach, Christian J. Buchholz, Raúl Torres, et al.
The Lancet (2023) Vol. 403, Iss. 10426, pp. 568-582
Closed Access | Times Cited: 41
Current and future immunotherapeutic approaches in pancreatic cancer treatment
Pooya Farhangnia, Hossein Khorramdelazad, Hamid Nickho, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 29
Allogeneic CD33-directed CAR-NKT cells for the treatment of bone marrow-resident myeloid malignancies
Yan-Ruide Li, Ying Fang, Shaoqiang Niu, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access | Times Cited: 2
Human NK cells: From development to effector functions
Arosh S. Perera Molligoda Arachchige
Innate Immunity (2021) Vol. 27, Iss. 3, pp. 212-229
Open Access | Times Cited: 97
CAR-T Cell Therapy: Mechanism, Management, and Mitigation of Inflammatory Toxicities
Joseph W. Fischer, Nirjal Bhattarai
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 71
Development of allogeneic HSC-engineered iNKT cells for off-the-shelf cancer immunotherapy
Yan-Ruide Li, Yang Zhou, Kwang Gi Kim, et al.
Cell Reports Medicine (2021) Vol. 2, Iss. 11, pp. 100449-100449
Open Access | Times Cited: 71
Advances in NK cell production
Fang Fang, Siqi Xie, Minhua Chen, et al.
Cellular and Molecular Immunology (2022) Vol. 19, Iss. 4, pp. 460-481
Open Access | Times Cited: 66
Chimeric Antigen Receptor-Engineered Natural Killer (CAR NK) Cells in Cancer Treatment; Recent Advances and Future Prospects
Reza Elahi, Amir Hossein Heidary, Kaveh Hadiloo, et al.
Stem Cell Reviews and Reports (2021) Vol. 17, Iss. 6, pp. 2081-2106
Open Access | Times Cited: 62
EZH1 repression generates mature iPSC-derived CAR T cells with enhanced antitumor activity
Ran Jing, Irene Scarfo, Mohamad Najia, et al.
Cell stem cell (2022) Vol. 29, Iss. 8, pp. 1181-1196.e6
Open Access | Times Cited: 61
piggyBac system to co-express NKG2D CAR and IL-15 to augment the in vivo persistence and anti-AML activity of human peripheral blood NK cells
Zhicheng Du, Yu Yang Ng, Shijun Zha, et al.
Molecular Therapy — Methods & Clinical Development (2021) Vol. 23, pp. 582-596
Open Access | Times Cited: 58
Integration of CRISPR/Cas9 with artificial intelligence for improved cancer therapeutics
Ajaz A. Bhat, Sabah Nisar, Soumi Mukherjee, et al.
Journal of Translational Medicine (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 47
Human natural killer cells: Form, function, and development
Emily M. Mace
Journal of Allergy and Clinical Immunology (2022) Vol. 151, Iss. 2, pp. 371-385
Open Access | Times Cited: 46
Application of lipid nanovesicle drug delivery system in cancer immunotherapy
Yinan Ding, Luhong Wang, Han Li, et al.
Journal of Nanobiotechnology (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 43
CAR-NK cells in combination therapy against cancer: A potential paradigm
Junping Li, Hong‐Ming Hu, Kai Lian, et al.
Heliyon (2024) Vol. 10, Iss. 5, pp. e27196-e27196
Open Access | Times Cited: 12
CD28 Costimulation Augments CAR Signaling in NK Cells via the LCK/CD3ζ/ZAP70 Signaling Axis
Sunil Acharya, Rafet Başar, May Daher, et al.
Cancer Discovery (2024) Vol. 14, Iss. 10, pp. 1879-1900
Closed Access | Times Cited: 10
NKG2D Natural Killer Cell Receptor—A Short Description and Potential Clinical Applications
Jagoda Siemaszko, Aleksandra Marzec-Przyszlak, Katarzyna Bogunia‐Kubik
Cells (2021) Vol. 10, Iss. 6, pp. 1420-1420
Open Access | Times Cited: 51
Chimeric antigen receptor-engineered NK cells: new weapons of cancer immunotherapy with great potential
Xiao Wang, Xuejiao Yang, Xiang Yuan, et al.
Experimental Hematology and Oncology (2022) Vol. 11, Iss. 1
Open Access | Times Cited: 35
CAR-NK Cells: A Chimeric Hope or a Promising Therapy?
Mohamad Sabbah, Ludovic Jondreville, Claire Lacan, et al.
Cancers (2022) Vol. 14, Iss. 15, pp. 3839-3839
Open Access | Times Cited: 31
Immunotherapy for the treatment of multiple myeloma
Leora Boussi, Zachary M. Avigan, Jacalyn Rosenblatt
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 28
GMP-Compliant Universal Antigen Presenting Cells (uAPC) Promote the Metabolic Fitness and Antitumor Activity of Armored Cord Blood CAR-NK Cells
Enli Liu, Sonny Ang, Lucila Nassif Kerbauy, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 40
Page 1 - Next Page

Scroll to top